424 related articles for article (PubMed ID: 11313871)
1. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
[TBL] [Abstract][Full Text] [Related]
2. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
[TBL] [Abstract][Full Text] [Related]
3. Critical contribution of the MDM2 acidic domain to p53 ubiquitination.
Kawai H; Wiederschain D; Yuan ZM
Mol Cell Biol; 2003 Jul; 23(14):4939-47. PubMed ID: 12832479
[TBL] [Abstract][Full Text] [Related]
4. The MDM2 RING-finger domain is required to promote p53 nuclear export.
Geyer RK; Yu ZK; Maki CG
Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
[TBL] [Abstract][Full Text] [Related]
5. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
Honda R; Tanaka H; Yasuda H
FEBS Lett; 1997 Dec; 420(1):25-7. PubMed ID: 9450543
[TBL] [Abstract][Full Text] [Related]
6. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.
Stad R; Little NA; Xirodimas DP; Frenk R; van der Eb AJ; Lane DP; Saville MK; Jochemsen AG
EMBO Rep; 2001 Nov; 2(11):1029-34. PubMed ID: 11606419
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
8. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
Honda R; Yasuda H
Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
[TBL] [Abstract][Full Text] [Related]
9. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
[TBL] [Abstract][Full Text] [Related]
11. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
12. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
Yu ZK; Geyer RK; Maki CG
Oncogene; 2000 Nov; 19(51):5892-7. PubMed ID: 11127820
[TBL] [Abstract][Full Text] [Related]
13. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
14. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
15. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
Li L; Liao J; Ruland J; Mak TW; Cohen SN
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
[TBL] [Abstract][Full Text] [Related]
16. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability.
Dolezelova P; Cetkovska K; Vousden KH; Uldrijan S
FEBS Lett; 2012 Jul; 586(16):2225-31. PubMed ID: 22659184
[TBL] [Abstract][Full Text] [Related]
18. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
19. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
O'Keefe K; Li H; Zhang Y
Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
[TBL] [Abstract][Full Text] [Related]
20. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
Xirodimas DP; Stephen CW; Lane DP
Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
